skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

This content will become publicly available on February 9, 2021

Title: Benchmark Dose Analysis of DNA Damage Biomarker Responses Provides Compound Potency and Adverse Outcome Pathway Information for the Topoisomerase II Inhibitor Class of Compounds

Authors:
ORCiD logo [1];  [2];  [2];  [2];  [2]; ORCiD logo [1]
  1. Institute of Life Science, Swansea University Medical School, Swansea University Wales United Kingdom
  2. Litron Laboratories Rochester New York
Publication Date:
Sponsoring Org.:
USDOE Office of Electricity Delivery and Energy Reliability (OE), Power Systems Engineering Research and Development (R&D) (OE-10)
OSTI Identifier:
1598725
Resource Type:
Publisher's Accepted Manuscript
Journal Name:
Environmental and Molecular Mutagenesis
Additional Journal Information:
Journal Name: Environmental and Molecular Mutagenesis; Journal ID: ISSN 0893-6692
Publisher:
Wiley Blackwell (John Wiley & Sons)
Country of Publication:
United States
Language:
English

Citation Formats

Wheeldon, Ryan P., Bernacki, Derek T., Dertinger, Stephen D., Bryce, Steven M., Bemis, Jeffrey C., and Johnson, George E. Benchmark Dose Analysis of DNA Damage Biomarker Responses Provides Compound Potency and Adverse Outcome Pathway Information for the Topoisomerase II Inhibitor Class of Compounds. United States: N. p., 2020. Web. doi:10.1002/em.22360.
Wheeldon, Ryan P., Bernacki, Derek T., Dertinger, Stephen D., Bryce, Steven M., Bemis, Jeffrey C., & Johnson, George E. Benchmark Dose Analysis of DNA Damage Biomarker Responses Provides Compound Potency and Adverse Outcome Pathway Information for the Topoisomerase II Inhibitor Class of Compounds. United States. doi:10.1002/em.22360.
Wheeldon, Ryan P., Bernacki, Derek T., Dertinger, Stephen D., Bryce, Steven M., Bemis, Jeffrey C., and Johnson, George E. Mon . "Benchmark Dose Analysis of DNA Damage Biomarker Responses Provides Compound Potency and Adverse Outcome Pathway Information for the Topoisomerase II Inhibitor Class of Compounds". United States. doi:10.1002/em.22360.
@article{osti_1598725,
title = {Benchmark Dose Analysis of DNA Damage Biomarker Responses Provides Compound Potency and Adverse Outcome Pathway Information for the Topoisomerase II Inhibitor Class of Compounds},
author = {Wheeldon, Ryan P. and Bernacki, Derek T. and Dertinger, Stephen D. and Bryce, Steven M. and Bemis, Jeffrey C. and Johnson, George E.},
abstractNote = {},
doi = {10.1002/em.22360},
journal = {Environmental and Molecular Mutagenesis},
number = ,
volume = ,
place = {United States},
year = {2020},
month = {2}
}

Journal Article:
Free Publicly Available Full Text
This content will become publicly available on February 9, 2021
Publisher's Version of Record

Save / Share:

Works referenced in this record:

The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing
journal, November 2008

  • Deweese, J. E.; Osheroff, N.
  • Nucleic Acids Research, Vol. 37, Issue 3
  • DOI: 10.1093/nar/gkn937

DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.
journal, March 1994

  • Nelson, W. G.; Kastan, M. B.
  • Molecular and Cellular Biology, Vol. 14, Issue 3
  • DOI: 10.1128/MCB.14.3.1815

DNA Ligase IV Deficiency in Mice Leads to Defective Neurogenesis and Embryonic Lethality via the p53 Pathway
journal, June 2000


Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development
journal, April 2000

  • Gao, Yijie; Ferguson, David O.; Xie, Wei
  • Nature, Vol. 404, Issue 6780
  • DOI: 10.1038/35009138

γH2AX and p53 responses in TK6 cells discriminate promutagens and nongenotoxicants in the presence of rat liver S9: γH2AX and p53 Responses in TK6 Cells
journal, July 2016

  • Bernacki, Derek T.; Bryce, Steven M.; Bemis, Jeffrey C.
  • Environmental and Molecular Mutagenesis, Vol. 57, Issue 7
  • DOI: 10.1002/em.22028

p53 mutated in the transactivation domain retains regulatory functions in homology-directed double-strand break repair
journal, June 2003


Stabilization of Eukaryotic Topoisomerase II-DNA Cleavage Complexes
journal, January 2003


Predictions of genotoxic potential, mode of action, molecular targets, and potency via a tiered multiflow® assay data analysis strategy: Tiered Data Analysis Strategy
journal, February 2019

  • Dertinger, Stephen D.; Kraynak, Andrew R.; Wheeldon, Ryan P.
  • Environmental and Molecular Mutagenesis, Vol. 60, Issue 6
  • DOI: 10.1002/em.22274

DNA topoisomerase II, genotoxicity, and cancer
journal, October 2007

  • McClendon, A. Kathleen; Osheroff, Neil
  • Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 623, Issue 1-2
  • DOI: 10.1016/j.mrfmmm.2007.06.009

Distinguishing between expert and statistical systems for application under ICH M7
journal, March 2017


A new method for determining allowable daily intakes*1
journal, October 1984


Quantitative approaches for assessing dose-response relationships in genetic toxicology studies
journal, September 2012

  • Gollapudi, B. B.; Johnson, G. E.; Hernandez, L. G.
  • Environmental and Molecular Mutagenesis, Vol. 54, Issue 1
  • DOI: 10.1002/em.21727

In Silico Tools for Sharing Data and Knowledge on Toxicity and Metabolism: Derek for Windows, Meteor, and Vitic
journal, January 2008

  • Marchant, Carol A.; Briggs, Katharine A.; Long, Anthony
  • Toxicology Mechanisms and Methods, Vol. 18, Issue 2-3
  • DOI: 10.1080/15376510701857320

Type II DNA topoisomerases
journal, February 1998


Application of the adverse outcome pathway framework to genotoxic modes of action
journal, October 2019

  • Sasaki, Jennifer C.; Allemang, Ashley; Bryce, Steven M.
  • Environmental and Molecular Mutagenesis, Vol. 61, Issue 1
  • DOI: 10.1002/em.22339

IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure–response relationships and points of departure (PoDs)
journal, May 2015

  • MacGregor, James T.; Frötschl, Roland; White, Paul A.
  • Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 783
  • DOI: 10.1016/j.mrgentox.2014.09.011

An appraisal of critical effect sizes for the benchmark dose approach to assess dose–response relationships in genetic toxicology
journal, August 2017

  • Zeller, Andreas; Duran-Pacheco, Gonzalo; Guérard, Melanie
  • Archives of Toxicology, Vol. 91, Issue 12
  • DOI: 10.1007/s00204-017-2037-3

Phosphoacetylation of histone H3 on c- fos - and c- jun -associated nucleosomes upon gene activation
journal, July 2000

  • Clayton, Alison L.; Rose, Sally; Barratt, Michael J.
  • The EMBO Journal, Vol. 19, Issue 14
  • DOI: 10.1093/emboj/19.14.3714

p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches
journal, June 1995


Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways
journal, January 2010


Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity
journal, November 2017


Genotoxic mode of action predictions from a multiplexed flow cytometric assay and a machine learning approach: Genotoxic Mode of Action Predictions
journal, January 2016

  • Bryce, Steven M.; Bernacki, Derek T.; Bemis, Jeffrey C.
  • Environmental and Molecular Mutagenesis, Vol. 57, Issue 3
  • DOI: 10.1002/em.21996

Shape and steepness of toxicological dose–response relationships of continuous endpoints
journal, November 2013


Investigating the Generalizability of the MultiFlow ® DNA Damage Assay and Several Companion Machine Learning Models With a Set of 103 Diverse Test Chemicals
journal, November 2017

  • Bryce, Steven M.; Bernacki, Derek T.; Smith-Roe, Stephanie L.
  • Toxicological Sciences, Vol. 162, Issue 1
  • DOI: 10.1093/toxsci/kfx235

The interaction of p53 with replication protein A mediates suppression of homologous recombination
journal, October 2004

  • Romanova, Larisa Y.; Willers, Henning; Blagosklonny, Mikhail V.
  • Oncogene, Vol. 23, Issue 56
  • DOI: 10.1038/sj.onc.1207982

IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk
journal, May 2015

  • MacGregor, James T.; Frötschl, Roland; White, Paul A.
  • Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 783
  • DOI: 10.1016/j.mrgentox.2014.10.008

Mechanism of Quinolone Action and Resistance
journal, March 2014

  • Aldred, Katie J.; Kerns, Robert J.; Osheroff, Neil
  • Biochemistry, Vol. 53, Issue 10
  • DOI: 10.1021/bi5000564

Wild-type p53 stimulates homologous recombination upon sequence-specific binding to the ribosomal gene cluster repeat
journal, March 2005


Core histone N-termini play an essential role in mitotic chromosome condensation
journal, February 2000


Dose-Response Modeling of Continuous Endpoints
journal, April 2002


Apoptosis Induced by DNA Topoisomerase I and II Inhibitors in Human Leukemic HL-60 Cells
journal, January 1994


Molecular docking studies on thirteen fluoroquinolines with human topoisomerase II a and b
journal, June 2017

  • Jadhav, Ashwini Khanderao; Karuppayil, Sankunny Mohan
  • In Silico Pharmacology, Vol. 5, Issue 1
  • DOI: 10.1007/s40203-017-0024-2

Phosphorylation of histone H3 correlates with transcriptionally active loci
journal, December 2000


Stimulation of Topoisomerase II-Mediated DNA Damage via a Mechanism Involving Protein Thiolation
journal, March 2001

  • Wang, Huimin; Mao, Yong; Chen, Allan Y.
  • Biochemistry, Vol. 40, Issue 11
  • DOI: 10.1021/bi002786j

Interpreting in vitro micronucleus positive results: Simple biomarker matrix discriminates clastogens, aneugens, and misleading positive agents: Interpreting In Vitro Micronucleus Positive Results
journal, April 2014

  • Bryce, Steven M.; Bemis, Jeffrey C.; Mereness, Jared A.
  • Environmental and Molecular Mutagenesis, Vol. 55, Issue 7
  • DOI: 10.1002/em.21868

Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations: Next Generation Testing Strategy for Assessment of Genomic Damage
journal, September 2016

  • Dearfield, Kerry L.; Gollapudi, B. Bhaskar; Bemis, Jeffrey C.
  • Environmental and Molecular Mutagenesis, Vol. 58, Issue 5
  • DOI: 10.1002/em.22045

A Critical Role for DNA End-Joining Proteins in Both Lymphogenesis and Neurogenesis
journal, December 1998


Comparison of in vitro and in vivo clastogenic potency based on benchmark dose analysis of flow cytometric micronucleus data
journal, June 2015

  • Bemis, Jeffrey C.; Wills, John W.; Bryce, Steven M.
  • Mutagenesis, Vol. 31, Issue 3
  • DOI: 10.1093/mutage/gev041

Empirical analysis of BMD metrics in genetic toxicology part I: in vitro analyses to provide robust potency rankings and support MOA determinations
journal, December 2015

  • Wills, John W.; Johnson, George E.; Doak, Shareen H.
  • Mutagenesis, Vol. 31, Issue 3
  • DOI: 10.1093/mutage/gev085

Estimating the carcinogenic potency of chemicals from the in vivo micronucleus test
journal, July 2015

  • Soeteman-Hernández, Lya G.; Johnson, George E.; Slob, Wout
  • Mutagenesis, Vol. 31, Issue 3
  • DOI: 10.1093/mutage/gev043

Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay: Multiplexed High Information Content Assay
journal, March 2017

  • Bryce, Steven M.; Bernacki, Derek T.; Bemis, Jeffrey C.
  • Environmental and Molecular Mutagenesis, Vol. 58, Issue 3
  • DOI: 10.1002/em.22083

Catalytic topoisomerase II inhibitors in cancer therapy
journal, August 2003

  • Larsen, Annette K.; Escargueil, Alexandre E.; Skladanowski, Andrzej
  • Pharmacology & Therapeutics, Vol. 99, Issue 2
  • DOI: 10.1016/S0163-7258(03)00058-5